Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study.

Burabha PussadhammaThapanee TipparotNaruemol ChaosuwannakitAjanee MahakkanukrauhSiraphop SuwannarojRatanavadee NanagaraChingching Foocharoen

Published in: International journal of rheumatology (2020)

Moderate-dose steroid therapy may improve myocarditis in SSc. A proportion of patients died due to cardiac complications during treatment, particularly those with high hs-cTnT, high NT-proBNP, and impaired LVEF. This trial is registered with NCT03607071.

Keyphrases

systemic sclerosis
interstitial lung disease
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
clinical trial
left ventricular
prognostic factors
study protocol
phase iii
rheumatoid arthritis
phase ii
patient reported outcomes
idiopathic pulmonary fibrosis
bone marrow
open label